Diroximel Fumarate
Brand name: Vumerity
Rank #259 of 500 drugs by total cost
$48.5M
Total Cost
5,351
Total Claims
$48.5M
Total Cost
260
Prescribers
$9,059
Cost per Claim
15
Beneficiaries
5,563
30-Day Fills
$186K
Avg Cost/Provider
21
Avg Claims/Provider
About Diroximel Fumarate
Diroximel Fumarate (sold as Vumerity) was prescribed 5,351 times by 260 Medicare Part D providers in 2023, costing the program $48.5M. At $9,059 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 256 | Donepezil Hcl (Donepezil Hcl) | $50.3M | 3,178,215 |
| 257 | Paliperidone (Paliperidone Er) | $49.3M | 129,516 |
| 258 | Sucralfate (Sucralfate) | $48.5M | 689,007 |
| 259 | Diroximel Fumarate (Vumerity) | $48.5M | 5,351 |
| 260 | Cabotegravir/Rilpivirine (Cabenuva) | $48.1M | 7,384 |
| 261 | Cenobamate (Xcopri) | $47.6M | 33,831 |
| 262 | Clozapine (Clozapine) | $47.0M | 491,951 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology